Home › Funds › Mizuho Markets Cayman LP › ADPT
Mizuho Markets Cayman LP position in ADPT
ADAPTIVE BIOTECHNOLOGIES COR · Health Care
Mizuho Markets Cayman LP reported holding 58,105 shares of ADPT (ADAPTIVE BIOTECHNOLOGIES COR) in its Q3 2026 13F filing — a position valued at US$1.7M, representing 0.12% of its reported portfolio and ranking #50 among its reported holdings. Mizuho Markets Cayman LP first reported this position in Q3 2026.
Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR
How Mizuho Markets Cayman LP's ADPT position evolved
Mizuho Markets Cayman LP first disclosed a stake in ADPT in Q3 2026 at 58,105 shares (US$1.7M).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2026 | 58.10K | $1.68M | New |
About ADPT and 13F data
ADPT (ADAPTIVE BIOTECHNOLOGIES COR) is a Health Care company. 58 other funds we track also report a position in ADPT — the largest reported positions include Viking Global Investors (US$643.4M), VIKING GLOBAL INVESTORS LP (US$643.4M), Aristotle Atlantic Partners, LLC (US$39.4M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding ADPT
- Viking Global Investors 29.99M sh · $643.37M · Q2 2026
- VIKING GLOBAL INVESTORS LP 29.99M sh · $643.37M · Q2 2026
- Aristotle Atlantic Partners, LLC 1.84M sh · $39.44M · Q2 2026
- PERCEPTIVE ADVISORS LLC 1.22M sh · $26.11M · Q2 2026
- Blue Water Life Science Advisors, LP 1.01M sh · $21.67M · Q2 2026
- Granite Investment Partners, LLC 628.10K sh · $18.15M · Q3 2026
- NEXT CENTURY GROWTH INVESTORS LLC 622.89K sh · $18.00M · Q3 2026
- Hillsdale Investment Management Inc. 551.35K sh · $15.93M · Q3 2026
More on Mizuho Markets Cayman LP
FAQ
How long has Mizuho Markets Cayman LP held ADPT?
Mizuho Markets Cayman LP has disclosed ADPT holdings in 1 of the last 1 reported quarters, going back to Q3 2026.
What is Mizuho Markets Cayman LP's current position in ADPT?
As of Q3 2026, Mizuho Markets Cayman LP holds 58.10K shares of ADPT (ADAPTIVE BIOTECHNOLOGIES COR), valued at $1.68M, representing 0.12% of its reported portfolio and ranking #50.
Has Mizuho Markets Cayman LP been buying or selling ADPT?
In the latest 13F filing (Q3 2026), Mizuho Markets Cayman LP newly opened its position in ADPT.
Which other funds hold ADPT?
Other major institutional holders of ADPT include Viking Global Investors, VIKING GLOBAL INVESTORS LP, Aristotle Atlantic Partners, LLC, among 58 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.